Announced Tue, 27 Oct, 2026 · 17:59 IST
Corporate governance filing not required for Q2 FY2026-27
MONOPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction
Awaiting price reaction for this filing.
AI summary
Mono Pharmcare need not submit a separate quarterly corporate governance report for the quarter ended September 30, 2026 because its shares are listed on the SME exchange. Bigshare Services reported no investor complaints during the quarter: zero received, resolved or pending.
Likely market impact
This is a routine regulatory exemption with no direct change to operations or financials. The zero investor complaint count is neutral for shareholders.